Supplementary Table S1 from Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling
James S. Hardwick(United States Military Academy), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Rosemary C. McFall(United States Military Academy), Michael E. Severino(United States Military Academy), Robert L. Phillips(American Academy of Family Physicians), Edward J. Weinstein(Harvard University), Elizabeth J. Koury(United States Military Academy), Bin Shi(Fudan University), Hongyue Dai(Rosetta Stone (United States)), Chunsheng Zhang(Rosetta Stone (United States)), John R. Lamb(Genomics Institute of the Novartis Research Foundation), Yi Yang, Susan L. Hill(United States Military Academy), Robert H. Wasserman, Nancy E. Kohl(United States Military Academy)
Cited by 0
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
|Cancer Immunology Research|2015|440
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409